PNC Financial Services Group
AVXL icon

PNC Financial Services Group’s Anavex Life Sciences AVXL Stock Holding History

PNC Financial Services Group’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$173K Buy
66,622
+4,530
+7% +$13.4K ﹤0.01% 2568
2026
Q1 		$191K Sell
62,092
-1,595
-3% -$6.91K ﹤0.01% 2355
2025
Q4 		$227K Sell
63,687
-341
-0.5% -$2.09K ﹤0.01% 2207
2025
Q3 		$570K Buy
64,028
+517
+0.8% +$5.24K ﹤0.01% 1561
2025
Q2 		$586K Buy
63,511
+5,838
+10% +$49.8K ﹤0.01% 1450
2025
Q1 		$495K Buy
57,673
+9,966
+21% +$94.1K ﹤0.01% 1522
2024
Q4 		$512K Hold
47,707
– – ﹤0.01% 1510
2024
Q3 		$271K Buy
47,707
+8,400
+21% +$48.5K ﹤0.01% 1967
2024
Q2 		$166K Buy
39,307
+16,353
+71% +$66.1K ﹤0.01% 2276
2024
Q1 		$117K Buy
22,954
+5,222
+29% +$29.4K ﹤0.01% 2519
2023
Q4 		$165K Buy
17,732
+280
+2% +$1.93K ﹤0.01% 2287
2023
Q3 		$114K Sell
17,452
-1,262
-7% -$10K ﹤0.01% 2489
2023
Q2 		$152K Buy
18,714
+1,262
+7% +$10.8K ﹤0.01% 2390
2023
Q1 		$150K Buy
17,452
+2,000
+13% +$20K ﹤0.01% 2325
2022
Q4 		$143K Buy
15,452
+2,000
+15% +$21.4K ﹤0.01% 2346
2022
Q3 		$139K Buy
13,452
+6,000
+81% +$63.3K ﹤0.01% 2324
2022
Q2 		$75K Buy
7,452
+4,518
+154% +$42.8K ﹤0.01% 2758
2022
Q1 		$36K Buy
2,934
+482
+20% +$5.93K ﹤0.01% 3279
2021
Q4 		$43K Buy
2,452
+452
+23% +$8.59K ﹤0.01% 3185
2021
Q3 		$36K Hold
2,000
– – ﹤0.01% 3247
2021
Q2 		$46K Buy
+2,000
New +$29.6K ﹤0.01% 3109
2017
Q1 		– Sell
-600
Closed -$2K – 4110
2016
Q4 		$2K Buy
+600
New +$2.14K ﹤0.01% 3820

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

PNC Financial Services Group's AVXL Position: Q2 2026 in Review

PNC Financial Services Group increased its Anavex Life Sciences (AVXL) stake by 7.3% in Q2 2026, buying an estimated $13.4K and bringing the position to 66,622 shares worth $173K. The position accounts for ﹤0.01% of the portfolio, ranked #2568.

PNC Financial Services Group first reported a position in AVXL in Q4 2016 and has held it in 22 quarters since. The position peaked at $586K in Q2 2025. 79 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • PNC Financial Services Group held 66,622 shares of Anavex Life Sciences worth $173K as of Q2 2026.
  • PNC Financial Services Group bought 4,530 Anavex Life Sciences shares in Q2 2026, an estimated $13.4K.
  • Anavex Life Sciences made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #2568 holding.
  • PNC Financial Services Group first reported a position in Anavex Life Sciences in Q4 2016 and has held it in 22 quarters since.
  • PNC Financial Services Group's Anavex Life Sciences position peaked at $586K in Q2 2025.
  • 79 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.